HK Stock Market Move | XTALPI (02228) rose more than 9% in the afternoon. Co-founder voluntarily extends lock-up commitment, demonstrating confidence in development.

XTALPI (02228) rose by more than 9%, reaching a 6.67% increase to HK$8.48 by the time of publication, with a trading volume of HK$7.87 billion. On the news front, on the evening of May 25, XTALPI announced that Dr. Wen Shuhao, Dr. Ma Jian and Dr. Lai Lipeng (all co-founders and executive directors of the company) will have their respective beneficial ownership lock-up commitments expire on June 12. The company has been informed that the founders have voluntarily extended the lock-up commitments until June 12 next year, during which time they will not sell the shares they own. The company noted that the founders' voluntary extension of the lock-up commitments demonstrates their confidence in the long-term value of the group, as the founders collectively hold approximately 12.9% of the shares. Additionally, Crystal Tai Technology recently shared the breakthrough achievements and industrial applications of its AI peptide drug design platform PepiX and generative AI-driven small nucleic acid drug development platform Kodexia at the 2026 TIDES USA. Building on its successes in small molecule and antibody drug discovery, Crystal Tai Technology's AI drug development platform in the peptide and small nucleic acid fields has also achieved commercial success, marking a new stage of scalable development in its intelligent drug development platform covering multiple drug modalities.